Hostname: page-component-76d6cb85b7-lcgwf Total loading time: 0 Render date: 2026-07-18T01:36:44.228Z Has data issue: false hasContentIssue false
  • English
  • Français

Detecting Residual Fluorine 18 From a Medical PET-CT Procedure During Population Whole Body Counter Screening in Fukushima

Published online by Cambridge University Press:  31 December 2014

Yoshitaka Nishikawa ,
Masaharu Tsubokura ,
Shigeaki Kato ,
Takeaki Ishii  and
Yasutoshi Saito
Yoshitaka Nishikawa*
Affiliation:
Department of Internal Medicine, Soma Central Hospital, Fukushima, Japan
Masaharu Tsubokura
Affiliation:
Department of Radiation Protection, Soma Central Hospital, Fukushima, Japan Division of Social Communication System for Advanced Clinical Research, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Shigeaki Kato
Affiliation:
Department of Radiation Protection, Soma Central Hospital, Fukushima, Japan
Takeaki Ishii
Affiliation:
Department of Orthopedic Surgery, Soma Central Hospital, Fukushima, Japan
Yasutoshi Saito
Affiliation:
Department of Internal Medicine, Soma Central Hospital, Fukushima, Japan
*
Correspondence and reprint requests to Yoshitaka Nishikawa, Department of Internal Medicine, Soma Central Hospital, Fukushima, Japan 3-5-8, Okinouchi, Soma city, Fukushima, 976-0016, Japan (e-mail: ynishikawa-tky@umin.ac.jp).
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content. As you have access to this content, full HTML content is provided on this page. A PDF of this content is also available in through the ‘Save PDF’ action button.

Information

Type
Letters to the Editor
Information
Disaster Medicine and Public Health Preparedness , Volume 8 , Issue 6 , December 2014 , pp. 469 - 470
Copyright
Copyright © Society for Disaster Medicine and Public Health, Inc. 2014 

After the Fukushima Daiichi nuclear incident in 2011, radiation contamination of the affected area raised public health concerns about internal radiation exposure.Reference Tsubokura, Gilmour and Takahashi 1 Internal radiation exposure screening using a whole body counter (WBC) (Fastscan Model 2251, Canberra Inc, Meriden, CT) has been performed for the affected residents in Soma City, 40 km north of the Fukushima Daiichi nuclear power plant (Figure 1). Analysis was performed by use of the Apex-InVivo and Genie software (Canberra Inc). Detection limits were 220 Bq for cesium 134 and 250 Bq for cesium 137 with a 2-minute scan.

Figure 1

Whole Body Counter. Internal radiation exposure screening has been performed by using a whole body counter in the affected areas of the 2011 Fukushima Daiichi nuclear power plant incident.

During a WBC screening of a 63-year-old examinee, a prominent peak at 511 keV was unexpectedly seen (Figure 2). Detailed history taking revealed that radioactive fluorine 18 (18F) fluorodeoxyglucose (FDG) was given to the patient the day before the WBC scan for the purpose of cancer screening by positron emission tomography (PET)/computed tomography (CT) scanning.

Figure 2

Results of Whole Body Counter Scanning. We unexpectedly detected a peak at 511 keV (left arrow) that overlapped with the radioactive cesium peak (middle arrow). Potassium 40 was detected at an ordinary level of 1725 Bq/body (right arrow).

FDG-PET/CT scanning is a diagnostic imaging technology that uses the two 511-keV gamma rays emitted at the moment of positron annihilation,Reference Delbeke, Coleman and Guiberteau 2 and the detected peak evidently reflects the remaining [18F]FDG. To our knowledge, this is the first report of detection of an [18F]FDG peak by WBC scanning.

Although the possibility of the presence of medical imaging and therapeutic radioactive isotopes has previously been described as a potential concern in homeland security screening,Reference Dauer, Williamson and Germain 3 , Reference Gitler 4 this case uncovered the undesirable aspect that FDG administered for PET/CT scanning shows a peak adjacent to those of target radionuclides for Fukushima Daiichi incident response WBC screening, such as cesium 134 and cesium 137. Clinicians should be careful not to overestimate the peaks from these target nuclides.

Together with the previous findings about detection of iodine 131 administered for thyroid cancer treatment,Reference Tsubokura, Nomura and Ishii 5 the present results suggest that careful history taking is pivotal for accurate assessment of radiation contamination among residents living in the area affected by the nuclear disaster.

References

1. Tsubokura, M, Gilmour, S, Takahashi, K, et al. Internal radiation exposure after the Fukushima nuclear power plant disaster. JAMA. 2012;308:669-670.Google Scholar
2. Delbeke, D, Coleman, RE, Guiberteau, MJ, et al. Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0. J Nucl Med. 2006;47:885-895.Google Scholar
3. Dauer, LT, Williamson, MJ St, Germain, J, et al. Tl-201 stress tests and homeland security. J Nucl Cardiol. 2007;14:582-588.Google Scholar
4. Gitler, B. Re: Tl-201 stress tests and homeland security. J Nucl Cardiol. 2007;14:904.Google Scholar
5. Tsubokura, M, Nomura, S, Ishii, T, et al. Detection of 131I in a patient with thyroid cancer by internal radiation exposure screening using a whole-body counter in Fukushima. Clin Nucl Med. 2014;39:281-282.Google Scholar
Figure 0

Figure 1 Whole Body Counter. Internal radiation exposure screening has been performed by using a whole body counter in the affected areas of the 2011 Fukushima Daiichi nuclear power plant incident.

Figure 1

Figure 2 Results of Whole Body Counter Scanning. We unexpectedly detected a peak at 511 keV (left arrow) that overlapped with the radioactive cesium peak (middle arrow). Potassium 40 was detected at an ordinary level of 1725 Bq/body (right arrow).